OC
LMAT icon

Oarsman Capital’s LeMaitre Vascular LMAT Stock Holding History

Oarsman Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-705
Closed -$65K – 576
2024
Q4 		$65K Buy
705
+47
+7% +$4.52K 0.01% 393
2024
Q3 		$61.1K Buy
+658
New +$57K 0.01% 418

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oarsman Capital's LMAT Position: Q1 2025 in Review

Oarsman Capital sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 705 shares — an estimated $65K sold.

Oarsman Capital first reported a position in LMAT in Q3 2024 and held it in 2 quarters. The position peaked at $65K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Oarsman Capital reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Oarsman Capital sold 705 LeMaitre Vascular shares in Q1 2025, an estimated $65K.
  • Oarsman Capital first reported a position in LeMaitre Vascular in Q3 2024 and held it in 2 quarters.
  • Oarsman Capital's LeMaitre Vascular position peaked at $65K in Q4 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.